Bryan H Chang (Bryan Chang)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Tyrosine Kinase

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas M Anderson, Bryan H Chang, Alexander C Huang, George X Xu, Daniel Yoon, Catherine G Shang, Rosemarie Mick, Erin Schubert, Suzanne McGettigan, Kristin Kreider, Wei Xu, E John Wherry, Lynn M Schuchter, Ravi K Amaravadi, Tara C Mitchell, Michael D Farwell
FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Thomas M Anderson, Bryan H Chang, Alexander C Huang, George X Xu, Daniel Yoon, Catherine G Shang, Rosemarie Mick, Erin Schubert, Suzanne McGettigan, Kristin Kreider, Wei Xu, E John Wherry, Lynn M Schuchter, Ravi K Amaravadi, Tara C Mitchell, Michael D Farwell
FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Thomas M Anderson, Bryan H Chang, Alexander C Huang, George X Xu, Daniel Yoon, Catherine G Shang, Rosemarie Mick, Erin Schubert, Suzanne McGettigan, Kristin Kreider, Wei Xu, E John Wherry, Lynn M Schuchter, Ravi K Amaravadi, Tara C Mitchell, Michael D Farwell
FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Thomas M Anderson, Bryan H Chang, Alexander C Huang, George X Xu, Daniel Yoon, Catherine G Shang, Rosemarie Mick, Erin Schubert, Suzanne McGettigan, Kristin Kreider, Wei Xu, E John Wherry, Lynn M Schuchter, Ravi K Amaravadi, Tara C Mitchell, Michael D Farwell
FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Thomas M Anderson, Bryan H Chang, Alexander C Huang, George X Xu, Daniel Yoon, Catherine G Shang, Rosemarie Mick, Erin Schubert, Suzanne McGettigan, Kristin Kreider, Wei Xu, E John Wherry, Lynn M Schuchter, Ravi K Amaravadi, Tara C Mitchell, Michael D Farwell
FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Thomas M Anderson, Bryan H Chang, Alexander C Huang, George X Xu, Daniel Yoon, Catherine G Shang, Rosemarie Mick, Erin Schubert, Suzanne McGettigan, Kristin Kreider, Wei Xu, E John Wherry, Lynn M Schuchter, Ravi K Amaravadi, Tara C Mitchell, Michael D Farwell
FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Thomas M Anderson, Bryan H Chang, Alexander C Huang, George X Xu, Daniel Yoon, Catherine G Shang, Rosemarie Mick, Erin Schubert, Suzanne McGettigan, Kristin Kreider, Wei Xu, E John Wherry, Lynn M Schuchter, Ravi K Amaravadi, Tara C Mitchell, Michael D Farwell
FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Thomas M Anderson, Bryan H Chang, Alexander C Huang, George X Xu, Daniel Yoon, Catherine G Shang, Rosemarie Mick, Erin Schubert, Suzanne McGettigan, Kristin Kreider, Wei Xu, E John Wherry, Lynn M Schuchter, Ravi K Amaravadi, Tara C Mitchell, Michael D Farwell
FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Thomas M Anderson, Bryan H Chang, Alexander C Huang, George X Xu, Daniel Yoon, Catherine G Shang, Rosemarie Mick, Erin Schubert, Suzanne McGettigan, Kristin Kreider, Wei Xu, E John Wherry, Lynn M Schuchter, Ravi K Amaravadi, Tara C Mitchell, Michael D Farwell
FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Kimberly J Edwards, Bryan H Chang, Hasan Babazada, Katheryn Lohith, Daniel H Park, Michael D Farwell, Mark A Sellmyer
Using CD69 PET Imaging to Monitor Immunotherapy-Induced Immune Activation. Cancer immunology research 10 (9) (2022)